Fatigue improvement/reduction with abiraterone acetate in patients with metastatic castration-resistant prostate cancer (mCRPC) post-docetaxel - Results from the COU-AA-301 phase 3 study Meeting Abstract


Authors: Sternberg, C. N.; Scher, H. I.; Molina, A.; North, S.; Mainwaring, P.; Hao, Y.; Gagnon, D.; Kheoh, T.; Haqq, C. M.; de Bono, J.
Abstract Title: Fatigue improvement/reduction with abiraterone acetate in patients with metastatic castration-resistant prostate cancer (mCRPC) post-docetaxel - Results from the COU-AA-301 phase 3 study
Meeting Title: 16th ECCO - 36th ESMO - 30th ESTRO European Multidisciplinary Cancer Congress (EMCC 2011)
Journal Title: European Journal of Cancer
Volume: 47
Issue: Suppl. 1
Meeting Dates: 2011 Sep 23-27
Meeting Location: Stockholm, Sweden
ISSN: 0959-8049
Publisher: Elsevier Inc.  
Date Published: 2011-09-01
Start Page: S488
End Page: S489
Language: English
ACCESSION: WOS:000295752801692
PROVIDER: wos
DOI: 10.1016/S0959-8049(11)71966-9
Notes: --- - Meeting Abstract: 7015 - European Multidisciplinary Cancer Congress on Integrating Basic and Translational Science, Surgery, Radiotherapy, Medical oncology, Advocacy and Care - SEP 23-27, 2011 - Stockholm, SWEDEN - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Howard Scher
    1130 Scher